Who owns REVOLUTION MEDICINES INC?
- CUSIP Number: 76155xaa8
Tip: Access positions for across all investors
Analyze quarterly positions in Revolution Medicines with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revolution Medicines stock
Who bought or sold REVOLUTION MEDICINES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 200M | $252M | 100% | Jun 2026 |
|
| Calamos Advisors | 36M | $45M | 100% | Jun 2026 |
|
| MacKay Shields | 30M | $38M | 100% | Jun 2026 |
|
| Linden Advisors | 29M | $36M | 100% | Jun 2026 |
|
| Zazove Associates | 22M | $28M | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 21M | $26M | 100% | Jun 2026 |
|
| BlackRock | 10M | $13M | 100% | Jun 2026 |
|
| Lord, Abbett & Co | 10M | $13M | 100% | Jun 2026 |
|
| M&G | 8.4M | $11M | 100% | Jun 2026 |
|
| Ameriprise Financial | 8.0M | $10M | 100% | Jun 2026 |
|
| Franklin Resources | 6.5M | $8.1M | 100% | Jun 2026 |
|
| SSI Investment Management | 6.5M | $8.1M | 100% | Jun 2026 |
|
| Toronto-Dominion Bank | 5.8M | $7.2M | 100% | Jun 2026 |
|
| Millennium Management | 5.1M | $6.4M | 100% | Jun 2026 |
|
| FMR | 5.1M | $6.3M | 100% | Jun 2026 |
|
| Advent Capital Management | 4.5M | $5.6M | 100% | Jun 2026 |
|
| Nicholas Investments Partners | 4.3M | $5.4M | 100% | Jun 2026 |
|
| Bnp Paribas Investment Partners | 4.0M | $5.0M | 100% | Jun 2026 |
|
| State of Wisconsin Investment Board | 4.0M | $5.0M | 100% | Jun 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 3.8M | $4.8M | 100% | Jun 2026 |
|
| Jupiter Topco | 3.6M | $4.5M | 100% | Jun 2026 |
|
| OrbiMed Advisors | 3.5M | $4.4M | 100% | Jun 2026 |
|
| Context Capital Management | 3.0M | $3.8M | 100% | Jun 2026 |
|
| Wellesley Investment Advisors | 2.6M | $2.9B | 100% | Jun 2026 |
|
| Amundi | 2.5M | $3.1M | 100% | Jun 2026 |
|
| Tenor Capital Management | 2.0M | $2.5M | 100% | Jun 2026 |
|
| Agf Management | 1.8M | $2.2M | 100% | Jun 2026 |
|
| Groupama Asset Managment | 1.4M | $1.8M | 100% | Jun 2026 |
|
| RWC Asset Management | 1.3M | $1.6M | 100% | Jun 2026 |
|
| Oaktree Capital Management | 1.2M | $1.4M | 100% | Jun 2026 |
|
| Invesco | 1.0M | $1.2M | 100% | Jun 2026 |
|
| Nomura Asset Management International | 1.0M | $1.3M | 100% | Jun 2026 |
|
| Man Group | 1.0M | $1.3M | 100% | Jun 2026 |
|
| Barclays | 872k | $1.1M | 100% | Jun 2026 |
|
| Jane Street | 825k | $1.0M | 100% | Jun 2026 |
|
| Leucadia National Corporation | 662k | $836k | 100% | Jun 2026 |
|
| Calamos Wealth Management | 613k | $774k | 100% | Jun 2026 |
|
| Sei Investments | 350k | $437k | 100% | Jun 2026 |
|
| Kohlberg Kravis Roberts & Co | 250k | $314k | 100% | Jun 2026 |
|
| UBS Group | 78k | $98k | 100% | Jun 2026 |
|
| Loomis, Sayles and | 23k | $4.2M | 100% | Jun 2026 |
|